Archive · 3 Oct 2025
Study: India Faces Highest Chikungunya Risk in Long-Term
Chikungunya is a sickness that can spread from mosquitoes.
Scientists studied where this might be the biggest problem.
India is at the highest risk.
The study also shows that around 50% of people may have pain after the sickness is gone.
This can make everyday things hard.
While there is no specific cure, there are vaccines that can protect you.
India is projected to be most impacted by chikungunya, with 5.1 million at risk annually.
The study estimates 14.4 million people globally could be at risk each year.
Brazil and Indonesia are also expected to be highly affected.
Around 50% of those infected may face long-term health issues.
The study emphasizes the importance of preventative measures.
- Who
- Researchers at the London School of Hygiene and Tropical Medicine
- What
- A global study predicting chikungunya infection risk
- When
- The study was published in BMJ Global Health
- Where
- Focuses on global impacts, with India at highest risk
- Why
- To predict the burden of chikungunya and inform public health management
- Primary Risk Location
- India
- People at Risk in India (Annually)
- 5.1 million
- Global Infections (Annually)
- 14.4 million
- Mosquito Vectors
- Aedes aegypti and Aedes albopictus
- Symptoms
- High fever and severe joint pain
- Long-Term Disability
- Around 50% of those infected
- Countries with Highest Impact
- India, Brazil, and Indonesia
